UK’s NICE rejects Faslodex (fulvestrant) for treatment of metastatic breast cancer

Great Britain’s National Institute for Health and Clinical Excellence (NICE) has recommended against support of  Faslodex® (fulvestrant) in treatment for metastatic breast cancer as a result of its recent review and appraisal of the drug. Although the appraisal indicates that fulvestrant lacks sufficient benefit for overall survival, one of the two gold standards for treatment medications for metastatic disease), it also cites cost as a primary reason for the committee’s support of the drug. The committee recommended two other aromatase inibitors as alternatives to fulvestrant: Arimidex® (anastrozole) or Femara® (letrozole), both of which are significantly less expensive.

Treatment of metastatic cancer involves changes in chemotherapy, hormonal or targeted therapies in response to the cancer’s growth and development. As metastatic cancer continues its spread, treatment choices become fewer as time goes on. Some drugs work better than others for any number of unknown reasons, so the number of choices in the arsenal of therapies is important. Some 50 other countries include fulvestrant in the arsenal for metastatic breast cancer.

NICE refuses AstraZeneca breast cancer drug on NHS. By Ananya Mandal, MD. In 11-13-11

5 6 7 8
© 2004–2011 Donna Peach. All rights reserved.


One response to “UK’s NICE rejects Faslodex (fulvestrant) for treatment of metastatic breast cancer

  1. Hi. I just noticed that your web site looks like it has a few code errors at the very top of your website’s page. I’m not sure if everybody is getting this same bugginess when browsing your site? I am employing a totally different browser than most people, referred to as Opera, so that is what might be causing it? I just wanted to make sure you know. Thanks for posting some huge postings and I’ll try to return back with a completely different browser to check things out!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s